Julius Kalcevich

Julius Kalcevich

Director of Finance/CFO at CYTOPHAGE TECHNOLOGIES LTD.

Net worth: 8 270 $ as of 2024-03-30

49 year
Finance
Consumer Services
Commercial Services

Profile

Julius Kalcevich is currently the Chief Financial Officer at Cytophage Technologies Ltd.
He previously worked as a Director of Investment Banking at CIBC World Markets, Vice President at Dundee Capital Markets, Manager at Accenture LLP, Vice President at Duff & Phelps LLC, Partner at Bellotti Capital Partners, Chief Financial Officer & Secretary at iAnthus Capital Holdings, and Partner at Bg Partners Corp.
Kalcevich holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from McGill University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2022-10-02 435,282 ( 0.01% ) 8 270 $ 2024-03-30
2024-02-01 0 ( -.--% ) - $ 2024-03-30

Julius Kalcevich active positions

CompaniesPositionStart
CYTOPHAGE TECHNOLOGIES LTD. Director of Finance/CFO 2024-02-07
All active positions of Julius Kalcevich

Former positions of Julius Kalcevich

CompaniesPositionEnd
IANTHUS CAPITAL HOLDINGS, INC. Director of Finance/CFO 2022-11-13
Bg Partners Corp. Corporate Officer/Principal 2016-08-31
Bellotti Capital Partners, Inc. Corporate Officer/Principal 2015-06-30
Corporate Officer/Principal 2012-12-31
Corporate Officer/Principal 2011-03-31
See the detail of Julius Kalcevich's experience

Training of Julius Kalcevich

The Trustees of Columbia University in The City of New York Masters Business Admin
McGill University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Julius Kalcevich's experience

Connections

75

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
IANTHUS CAPITAL HOLDINGS, INC.

Process Industries

Private companies7

Finance

Commercial Services

Finance

Finance

Bellotti Capital Partners, Inc.

Bg Partners Corp.

Cytophage Technologies Ltd.

See company connections
  1. Stock Market
  2. Insiders
  3. Julius Kalcevich